As the NHS in all four nations continues preparations to manage winter clinical pressures, two NHS trusts have accelerated deployment of modules of their smart Electronic Patient Record Systems (EPRs), aimed at further improving patient safety in busy clinical settings while introducing efficiencies to streamline patients’ hospital stays.
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced new additions to its CT imaging portfolio at the Radiological Society of North America (RSNA) annual meeting (November 28 - December 2, Chicago, USA). The new CT 5100 - Incisive - features CT Smart Workflow[1], a comprehensive suite of artificial intelligence* (AI) enabled capabilities designed to
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced a collaboration with USA-based MedChat to integrate MedChat's live chat and AI-driven chatbot services into Philips Patient Navigation Manager, helping improve call center efficiency and speed the time to resolve patient inquiries.
15 - 18 November 2021, Düsseldorf, Germany.
The consolidation of a European framework and ecosystem of digital health solutions and services, covering technological and organisational innovation and addressing the needs of the involved stakeholders, including those of SMEs and start-ups.
Dedalus Group ("Dedalus"), a leading international healthcare software solutions provider, has announced to have completed the acquisition of 100% of Swiftqueue Technologies Ltd a fast-growing cloud-native appointment and scheduling solution provider.
The Cloud-native Swiftqueue solution enables patients and citizens to access healthcare services provided from hospitals, clinics and specialists through a digital front door.
This study presents an overview of the development, adoption and use of Artificial Intelligence (AI) technologies and applications in the healthcare sector across all Member States. The main aim of this study was to support the European Commission in identifying and addressing any issues that might be hindering the wider adoption of AI technologies in the healthcare sector. The study will help the Commission to take action to achieve its long-term goal on the effective implementation of AI in the healthcare sector, based around common legislation and policy framework.
The U.S. Food and Drug Administration today authorized marketing of EaseVRx, a prescription-use immersive virtual reality (VR) system that uses cognitive behavioral therapy and other behavioral methods to help with pain reduction in patients 18 years of age and older with diagnosed chronic lower back pain.